Found: 145
Select item for more details and to access through your institution.
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67906-w
- By:
- Publication type:
- Article
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1369601
- By:
- Publication type:
- Article
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369601
- By:
- Publication type:
- Article
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3270
- By:
- Publication type:
- Article
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367393
- By:
- Publication type:
- Article
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 3, p. 383, doi. 10.3390/pharmaceutics16030383
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3249
- By:
- Publication type:
- Article
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3931, doi. 10.1007/s00262-023-03559-4
- By:
- Publication type:
- Article
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 4251, doi. 10.1007/s10238-023-01244-5
- By:
- Publication type:
- Article
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272072
- By:
- Publication type:
- Article
Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1762, doi. 10.1002/ajh.27073
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 9, p. 3291, doi. 10.1007/s10072-023-06841-6
- By:
- Publication type:
- Article
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 4, p. 1197, doi. 10.1007/s10238-022-00877-2
- By:
- Publication type:
- Article
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1194712
- By:
- Publication type:
- Article
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1375, doi. 10.1007/s00277-023-05159-9
- By:
- Publication type:
- Article
Editorial: Measurable residual disease in hematologic malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1204393
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1162990
- By:
- Publication type:
- Article
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 363, doi. 10.1007/s10147-023-02295-0
- By:
- Publication type:
- Article
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1772, doi. 10.3390/jcm12051772
- By:
- Publication type:
- Article
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231190683
- By:
- Publication type:
- Article
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 54, doi. 10.1111/bjh.18385
- By:
- Publication type:
- Article
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 373, doi. 10.1111/ejh.13819
- By:
- Publication type:
- Article
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1017863
- By:
- Publication type:
- Article
AML-MRC e mutazione FLT3: quale gerarchia nella scelta terapeutica?
- Published in:
- Current Therapeutics, 2022, v. 25, n. 8, p. 8
- By:
- Publication type:
- Article
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31015-x
- By:
- Publication type:
- Article
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 6, p. 1305, doi. 10.3390/diagnostics12061305
- By:
- Publication type:
- Article
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3206, doi. 10.3390/jcm11113206
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1801, doi. 10.3390/jcm11071801
- By:
- Publication type:
- Article
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.839915
- By:
- Publication type:
- Article
Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review.
- Published in:
- Hematology Reports, 2022, v. 14, n. 1, p. 19, doi. 10.3390/hematolrep14010004
- By:
- Publication type:
- Article
Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.828072
- By:
- Publication type:
- Article
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 559, doi. 10.1111/bjh.17890
- By:
- Publication type:
- Article
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.835563
- By:
- Publication type:
- Article
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 31, doi. 10.1002/hon.2939
- By:
- Publication type:
- Article
Strategie terapeutiche in pazienti affetti da leucemia mieloide acuta ad alto rischio non candidabili al trapianto allogenico.
- Published in:
- Current Therapeutics, 2021, v. 24, n. 7, p. 3
- By:
- Publication type:
- Article
JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.
- Published in:
- European Heart Journal, 2021, v. 42, n. 42, p. 4389, doi. 10.1093/eurheartj/ehab447
- By:
- Publication type:
- Article
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1527, doi. 10.1080/0284186X.2021.1971292
- By:
- Publication type:
- Article
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.752192
- By:
- Publication type:
- Article
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1480, doi. 10.3390/biomedicines9101480
- By:
- Publication type:
- Article
Early Diagnosis of Neutropenic Enterocolitis by Bedside Ultrasound in Hematological Malignancies: A Prospective Study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01419-1
- By:
- Publication type:
- Article
CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S329, doi. 10.1016/S2152-2650(21)01772-9
- By:
- Publication type:
- Article
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090900
- By:
- Publication type:
- Article
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
- By:
- Publication type:
- Article
Assessment of droplet digital polymerase chain reaction for measuring BCR‐ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 53, doi. 10.1111/bjh.17521
- By:
- Publication type:
- Article
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.638689
- By:
- Publication type:
- Article
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.672287
- By:
- Publication type:
- Article